zZZiziphus

Australia - English - Department of Health (Therapeutic Goods Administration)

Buy It Now

Active ingredient:
Anemarrhena asphodeloides,Glycyrrhiza uralensis,Ligusticum striatum,Wolfiporia cocos,Ziziphus jujuba var. spinosa
Available from:
Sun Ten Chinaherb Co (Aust) Pty Ltd
Authorization status:
Listed
Authorization number:
350983

Read the complete document

Public Summary

Summary for ARTG Entry:

350983

zZZiziphus

ARTG entry for

Medicine Listed

Sponsor

Sun Ten Chinaherb Co (Aust) Pty Ltd

Postal Address

PO Box 1541, BONDI JUNCTION, NSW, 1355

Australia

ARTG Start Date

7/12/2020

Product Category

Medicine

Status

Active

Approval Area

Listed Medicines

Conditions

Colouring agents used in listed medicine for ingestion, other than those listed for export only under section 25 of the Act, shall be only those included in the list

of 'Colourings permitted in medicines for oral use'.

The sponsor shall keep records relating to this listed medicine as are necessary to: (a) Expedite recall if necessary of any batch of the listed medicine, (b)

Identify the manufacturer(s) of each batch of the listed medicine. Where any part of or step in manufacture in Australia of the listed medicine is sub-contracted

to a third party who is not the sponsor, copies of relevant Good Manufacturing Practice agreements relation to such manufacture shall be kept.

The sponsor shall retain records of the distribution of the listed medicine for a period of five years and shall provide the records or copies of the records to the

Complementary Medicines Branch, Therapeutic Goods Administration, upon request.

Where a listed medicine is distributed overseas as well as in Australia, product recall or any other regulatory action taken in relation to the medicine outside

Australia which has or may have relevance to the quality, safety or efficacy of the goods distributed in Australia, must be notified to the National Manager

Therapeutic Goods Administration, immediately the action or information is known to the sponsor.

Products

1 . zZZiziphus

Product Type

Single Medicine Product

Effective Date

7/12/2020

Permitted Indications

Traditionally used in Chinese medicine to nourish/tonify/replenish strenthen liver-blood

Traditionally used in Chinese medicine to relieve irritability

Traditionally used in Chinese medicine to calm/soothe/nourish/balance spirit

Traditionally used in Chinese medicine to decrease/reduce/relieve sleeplessness

Indication Requirements

Product presentation must not imply or refer to serious cardiovascular conditions.

Product presentation must not imply or refer to mental illnesses, disorders or conditions.

If TCM terminology is used on medicine label, label statement: Talk to a TCM practitioner/health professional if you are unsure if this medicine is right for

you.

Label statement: If symptoms persist, talk to your health professional.

Product presentation must not imply or refer to liver disease, such as cirrhosis, hepatitis.

Standard Indications

No Standard Indications included on Record

Specific Indications

No Specific Indications included on Record

Warnings

Contains lactose (or words to that effect).

(If medicine contains one sugar) contains [insert name of sugar] OR (If medicine contains two or more sugars) Contains sugars [or words to that effect].

Additional Product information

Pack Size/Poison information

Pack Size

Poison Schedule

Components

1 . Formulation 1

Public Summary

Page 1 of

Produced at 11.01.2021 at 09:11:21 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

Dosage Form

Granules

Route of Administration

Oral

Visual Identification

Active Ingredients

Anemarrhena asphodeloides rhizome Extract dry concentrate

66.67 mg/g

Equivalent: Anemarrhena asphodeloides (Dry)

333.33 mg/g

Glycyrrhiza uralensis root Extract dry concentrate

33.33 mg/g

Equivalent: Glycyrrhiza uralensis (Dry)

166.67 mg/g

Ligusticum striatum rhizome Extract dry concentrate

66.67 mg/g

Equivalent: Ligusticum striatum (Dry)

333.33 mg/g

Wolfiporia cocos fruiting body Extract dry concentrate

66.67 mg/g

Equivalent: Wolfiporia cocos (Dry)

333.33 mg/g

Ziziphus jujuba var. spinosa seed Extract dry concentrate

266.67 mg/g

Equivalent: Ziziphus jujuba var. spinosa (Dry)

1.33 g/g

Other Ingredients (Excipients)

lactose monohydrate

maltodextrin

© Commonwealth of Australia. This work is copyright. You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth. Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 2 of

Produced at 11.01.2021 at 09:11:21 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

Similar products

Search alerts related to this product

Share this information